This page is for the COO, platform lead or chief compliance officer of a fund that takes part in SourceX's referral program, or is deciding whether to. Whether to take part at all is weighed in should a venture fund accept data referral rewards. The line between referring companies and assessing SourceX as an investment is drawn in separating a company referral from an investment introduction. This page takes the narrower question those leave open: how a reward the fund might earn is kept from shaping which companies it backs, by how much and when. It gives no legal conclusion.
How a reward can reach an investment decision without anyone choosing it
SourceX screens companies on checks a deal team can mostly see from across the table: a full-time workforce that reached at least 50 at its high point, not counting contractors; a long run of the company's own operating records; clear rights to license them; a CEO who authorizes the discussion; and a match with a current program. None of those checks mentions funding. A fund that participates in the referral program can therefore start to see an older company with a large workforce and a long paper trail as a reward candidate before it sees it as an investment, and an associate can write a hoped-for payout into a memo as upside.
SEC staff describe a conflict of interest, in our paraphrase of search excerpts from their staff bulletin on conflicts, as an interest that might incline a firm or adviser, consciously or unconsciously, to give advice that is not disinterested. The same bulletin treats identifying and addressing conflicts as a robust, ongoing process tailored to each conflict rather than a formality, and says compliance can be hard to show without documented mitigation steps and periodic reviews. Whether that guidance governs your fund, and who your adviser's client is, are questions for fund counsel. The test still serves as a design rule: if a possible reward could incline anyone, even without their noticing, the decision it touches needs a control.
Who would receive a reward, and whose judgment it could pull
The sample Channel Partner Agreement names the Partner as "[an individual, or entity type and jurisdiction]", so the recipient can be a fund entity or a person. Name the recipient first, because it decides whose judgment is exposed.
| Recipient named on the signed agreement | Whose judgment the reward could pull | Strongest control |
|---|---|---|
| The management company | Every partner who shares in the management company's results | The memo line and committee controls below, with counsel's view on how the fund's documents treat outside income |
| A fund vehicle | The whole investment team, through the fund's own results | The same controls, recorded at committee level |
| One named partner | That partner's sourcing, sponsorship and votes | The partner records the interest before any vote on a company they could introduce; counsel decides on recusal |
| Nobody | A weaker pull from platform credit and goodwill | The screening and memo controls, kept for consistency |
How a firm's account relates to its people's personal accounts is not settled by the published terms; SourceX decides it, so ask SourceX before choosing a route. Partners sign the agreement before they submit introductions (terms, section 1).
The separation-of-decisions control map
Six decisions, each with the way a reward could tilt it, the control that blocks it, the person who owns that control and the record that shows the control ran.
| Decision | How a reward could tilt it | Control | Owner | Record that shows it ran |
|---|---|---|---|---|
| 1. Screening a new deal | Ranking companies higher because they resemble SourceX's fit profile | No referral or data licensing field in screening criteria or deal-stage records; sourcing notes never mention SourceX | Head of the investment team | Screening template reviewed once a year with the field absent |
| 2. The memo and the valuation | Counting a hoped-for reward, or an unsigned payout, as upside | A fixed memo line: "No referral reward to the fund or its people, and no unsigned data licensing payout, is counted in this memo" | Memo author; committee chair confirms | The line present in every memo |
| 3. Diligence material | Using data-room facts about systems and records to plan an introduction | Diligence material stays with the deal team under its confidentiality terms; no referral conversation with a company while the fund is negotiating to invest in it | Deal lead; compliance | A deal-file note at signing and again at closing |
| 4. Follow-on and reserves | Favoring a company that licensed data, or holding back from one that declined | A company's answer about SourceX is never recorded in portfolio reviews or follow-on papers; the referral log sits with the platform team, out of the committee's reach | Committee chair | Follow-on papers with no SourceX reference; struck remarks minuted |
| 5. Platform support | Steering scarce platform hours toward companies that could produce a reward | Support is allocated by the fund's written support criteria, and time is logged against them | Platform lead | A quarterly comparison of hours against the criteria |
| 6. A look at SourceX as an investment | Letting the referral relationship stand in for diligence, or letting an investment interest drive referrals | Different people in each lane; the referral relationship is never cited in an investment review of SourceX | Managing partner; compliance | A recusal entry wherever one person touches both |
Method note. The six decisions are this page's model of a venture investment cycle, written for this guide; they describe no particular fund. Who can be paid, and on what basis, comes from SourceX's program terms and the sample agreement; the design rule comes from the SEC staff bulletin as paraphrased above; all were read on 2026-10-28. Nothing here has been measured: no fund's records were reviewed, and no published evidence shows how well these controls work.
Two rows need a word of explanation. Row 3 sets a timing rule as well as a confidentiality one, because a company being courted for an investment is in no position to hear a referral suggestion as optional. Row 4 protects the founder as much as the fund: a CEO who declined SourceX should never find that answer resurfacing when the company needs money.
Two decisions at one committee meeting (Illustrative)
Illustrative. Both companies are made up, and nothing here predicts how a real committee would vote.
A new deal. An associate's memo on a 380-person claims administrator with 16 years of its own case records adds a line under upside: "data licensing payout via a SourceX referral." The committee chair strikes it under row 2, the memo goes back with the fixed line, and the vote proceeds on the business alone. Six months after closing, the CEO asks the platform lead about SourceX. The fund's chosen route applies, the disclosure goes out in writing, and the CEO decides. The deal team learns only what the CEO chooses to share.
A follow-on. At the same meeting a 140-person logistics software company asks for a follow-on. A partner remarks that its CEO "passed on SourceX." The chair stops the discussion under row 4, the minute records that the remark was struck, and the follow-on is decided on the company's plan. Whether the company would have passed SourceX's checks at all was never the committee's question; fit is decided in SourceX's own review, and the CEO decides whether to talk.
Duties, outside roles and conflicts the map cannot see
- Small partnerships. Where two partners do everything, separating people is impossible. Lean on the memo line, written records and counsel's view, or choose the unpaid route recorded in when a fund prefers unpaid introductions.
- Board seats. A partner on a portfolio company's board knows its systems from board materials. SourceX's screening page treats that knowledge as a reason to ask the CEO, never as material to pass along. The director's own position is covered in the board member reward question.
- Outside roles. Operating partners and venture partners with seats or retainers elsewhere need their own row on the recipient table; see the operating partner conflict inventory.
- The fund's documents. The LPA, side letters, Form ADV and compliance manual belong to the fund. Whether they address outside compensation, require disclosure to investors or call for any offset is fund counsel's question; this page says nothing about their contents. The money questions counsel tends to raise are gathered in the fund counsel briefing packet.
- Credit overlaps. If a co-investor also knows a company, only one introduction can be credited, and SourceX settles overlapping claims from dated records in its duplicate review. That outcome never enters an investment decision either.
Record the approved path
| Field | Entry |
|---|---|
| Participation route | Fund entity, named person or nobody, with the recipient's name |
| Counsel's sign-off | Date, and the controls counsel considered sufficient |
| Controls adopted | Rows 1 to 6, each with its owner |
| Recusals | Who stepped out of which decision, and when |
| Exceptions | Any struck memo line or remark, with the date |
| Review date | At least once a year, and whenever the participation route changes |
Where the controls fall short
- Unnoticed tilt. The staff bulletin's own wording allows for conflicts that work unconsciously. Records show that a control ran; they cannot show that nobody was swayed.
- Over-correction. Refusing to back a strong company because it resembles SourceX's fit profile is also a distortion. The controls remove the reward from the decision; they do not add a penalty.
- Paper compliance. A memo line can be pasted without being read. Spot checks by someone outside the deal team catch some of that.
- Untested. A fund can measure its own controls: once a year, sample its memos and follow-on minutes, count SourceX mentions and struck remarks, and report the counts to counsel. No such results have been published.
More fund guides are collected in the guides hub.
Next step
Refer a company. No cap on rewards. Default reward on a company's first qualifying transaction: the greater of $50,000 plus 5% and 15% of Actual Supplier Payout, with no cap; further qualifying transactions first agreed within 12 months of the first Closing pay 15%. Eligibility and payment conditions apply, including the USD 100,000 Minimum Transaction, and a signed Schedule A or addendum can differ. A lead, meeting or signature alone does not trigger payment.
Once counsel has signed off the recipient and the six controls, register the approved partner, compare a company with who qualifies only after its CEO raises the subject, and keep the program terms version on file with the control map.
Keeping rewards out of investment decisions is referral governance; assessing SourceX itself as an investment is a separate decision, handled by different people, and anyone weighing it can request investor materials through the SourceX investor overview.
This article is for information only and is not an offer to sell or a solicitation of an offer to buy securities. Any offering by SourceX is made only to verified accredited investors through its offering documents.